Beckar et al. [132] also showed that the administration of exogenous adenosine or an adenosine A1 receptor agonist (CCPA) directly into the VL nucleus of the thalamus inhibited tremor caused by harmaline, while the antagonist of these receptors (DPCPX) intensified tremor. The gene discussed is ADORA1; the disease is Tremor.